Editorial: One cedi in five

At the 131st Monetary Policy Committee (MPC) meeting’s outcome, the Bank of Ghana (BoG) kept its benchmark monetary policy rate unchanged at 14 percent.

Abstract Climate change is increasingly becoming one of the most significant systemic risks faced by the insurance industry of Africa. Across the continent, increased temperatures, unreliable rainfall, flooding, droughts, coastal erosion and extreme weather events have been causing massive economic losses and leading to a huge climate insurance protection gap.

 A couple of weeks ago, the Minerals Income Investment Fund (MIIF), the state entity set up by the Government of Ghana to manage the country’s mineral wealth through royalty collection and investment, published its audited financial performance for 2025, and the results are nothing but impressive demonstration of financial resilience by a state institution in recent times.

Parliament has approved nearly US$ 900 million in new external financing, prompting fresh debate over government’s fiscal strategy in the post-IMF era and whether weaker-than-expected domestic revenue mobilisation is forcing a quicker return to external borrowing for financing development priorities while preserving debt sustainability.

Ghana has completed its US$3billion International Monetary Fund (IMF) bailout programme after the Fund’s Executive Board approved the sixth and final review of the Extended Credit Facility (ECF), bringing to a close a three-year stabilisation programme launched following the country’s 2022 economic crisis.

IC Asset Managers (Ghana) Ltd. has launched IC Wealth on the MTN MoMo app, giving millions of mobile money customers direct access to the firm’s regulated investment products from their mobile phones.

GCB Bank PLC delivered a strong financial performance in the first half of 2026, recording robust growth in earnings and balance-sheet expansion despite a sharp decline in interest rates that compressed margins across the domestic banking industry.

The country's pharmaceutical industry is pressing for deliberate investment across the entire pharmaceutical value chain, arguing that the country's ambition to become a regional manufacturing hub will remain out of reach unless it moves beyond assembling finished medicines to producing critical inputs locally.